Overview
Infantile striatothalamic degeneration is an extremely rare neurological condition that was historically described as a distinct disorder affecting the brain, specifically the striatum and thalamus — two deep brain structures involved in movement control, sensation, and other vital functions. The term is now considered obsolete in medical classification, meaning that cases once labeled with this diagnosis have likely been reclassified under other, better-understood genetic or metabolic conditions as medical knowledge has advanced. In the original descriptions, affected infants typically showed severe neurological problems beginning very early in life, including abnormal muscle tone, movement difficulties, developmental delay, and progressive loss of brain function. The condition was associated with degeneration (breakdown) of nerve cells in the striatum and thalamus, which are critical relay centers in the brain. Because this diagnosis is now obsolete, families who were given this label in the past should work with a clinical geneticist or pediatric neurologist to determine whether modern genetic testing can identify a more specific underlying cause. Advances in genetic sequencing have allowed many previously unclassified conditions to be matched to specific gene changes, which can guide treatment and family planning decisions. Treatment has generally been supportive, focusing on managing symptoms such as seizures, feeding difficulties, and movement problems.
Key symptoms:
Severe developmental delayAbnormal muscle tone (too stiff or too floppy)Involuntary movementsDifficulty feedingSeizuresLoss of previously learned skillsPoor head controlIrritabilityFailure to thriveVision problemsDifficulty swallowing
Infantile
Begins in infancy, roughly 1 month to 2 years old
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Infantile striatothalamic degeneration.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Infantile striatothalamic degeneration at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Infantile striatothalamic degeneration.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Infantile striatothalamic degeneration.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Infantile striatothalamic degeneration.
Start the conversation →Latest news about OBSOLETE: Infantile striatothalamic degeneration
No recent news articles for OBSOLETE: Infantile striatothalamic degeneration.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Has modern genetic testing been done to identify the specific cause of my child's condition?,Would whole exome or whole genome sequencing be helpful in our case?,Are there any treatable conditions that could explain my child's symptoms?,What is the best seizure management plan for my child?,What feeding and nutrition support does my child need?,Are there any clinical trials or research studies we should consider?,What palliative or supportive care services are available to help our family?
Common questions about OBSOLETE: Infantile striatothalamic degeneration
What is OBSOLETE: Infantile striatothalamic degeneration?
Infantile striatothalamic degeneration is an extremely rare neurological condition that was historically described as a distinct disorder affecting the brain, specifically the striatum and thalamus — two deep brain structures involved in movement control, sensation, and other vital functions. The term is now considered obsolete in medical classification, meaning that cases once labeled with this diagnosis have likely been reclassified under other, better-understood genetic or metabolic conditions as medical knowledge has advanced. In the original descriptions, affected infants typically showe
At what age does OBSOLETE: Infantile striatothalamic degeneration typically begin?
Typical onset of OBSOLETE: Infantile striatothalamic degeneration is infantile. Age of onset can vary across affected individuals.